Pharmaceutical Technology, Jun 2, 2007 - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Pharmaceutical Technology, Jun 2, 2007
Nanotechnology Advances in Drug Delivery
By Patricia Van Arnum
Nanotechnology is emerging as a tool for resolving challenges in delivering poorly water soluble and highly potent drugs.
Solubility, Polymorphism, Crystallinity, Crystal Habit, and Drying Scheme of (R, S)-(±)-Sodium Ibuprofen Dihydrate
By Tu Lee , Ying Hsiu Chen , Chyong Wen Zhang
The racemic compound (R, S)-(±)-ibuprofen is a popular and well understood active pharmaceutical ingredient, but it has several disadvantageous formulation properties such as poor solubility, low melting point, and potential esterification with excipients containing an hydroxyl group. The authors investigate the use of an (R, S)-(±)-ibuprofen salt to evaluate these problems using various analytical methods to determine the polymorphism, crystallinity, and drying scheme.
Building Monoclonal Antibody Production
By Patricia Van Arnum
Pharma companies and CMOs build positions in mAbs.
Pharmaceutical Technology's Manufacturers' Rankings
By Erik Greb , Patricia Van Arnum
Pharmaceutical Technology's Annual Manufacturers' Rankings provides perspectives on revenues, product positioning, R&D spending, pharmaceutical manufacturing activity, and capital projects of the major drug companies.
Is Your Company Lucky or Smart?
By Jim Miller
While some companies float with the tide, others grab market share while business is good.
Washington Report
Manufacturing Issues Shape Follow-On Biologics Debate
By Jill Wechsler
Product characterization and production challenges are key issues in developing a pathway for biosimilar therapies.
Packaging Forum
Interphex Showcases Packaging Innovations
By Hallie Forcinio
Exhibitors' products prevent counterfeiting, provide child resistance, protect product quality, and improve packaging-line efficiency.
Out of Date, Out of Touch
By Control, a senior compliance officer
Look ahead to keep from falling behind.
Signature Authentication Can Restore Confidence
By Sam Barclay
Signature authentication technology has evolved to become a stong tool for improving confidence in verification.
From The Editor
Balancing Act
By Michelle Hoffman
Perhaps Congress can help FDA meet its multiple oversight demands.
This Time Around
Setting an Example
By Angie Drakulich
Global corporate citizenship can go a long way.
In the Spotlight
In the Spotlight
Editors' Picks of Pharmaceutical Science & Technology Innovations
In the Field
In The Field
Boston, MA (May 8)—The global biotechnology industry showed several positive signs in 2006, including increases in overall revenues and financing, although the industry as a whole continues to operate at a loss, according to Ernst & Young's (New York, NY, annual analysis of the biotechnology industry. Its report, "Beyond Borders 2007," was issued at the Biotechnology Industry Organization's (BIO, annual conference and exhibition, which was held in Boston May 6–9.
Pharma Capsules
Pharma Capsules
News and Views


LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
Click here